21
Participants
Start Date
February 7, 2020
Primary Completion Date
February 2, 2022
Study Completion Date
February 5, 2022
REx Condition First
REx condition: Participants will complete a whole-body REx workout consisting of 1-set to failure (e.g. RPE of 9-10 on 10-point scale on final reps) on 12 exercises in the Exercise Research Laboratory (located in the CTRC), with a 3-minute rest between exercises. Participants will complete the following exercises: leg press; leg extension; leg curl; hip abduction; hip adduction; chest press; overhead press; seated row; overheard pulldowns and assisted triceps dips on Cybex resistance equipment; barbell calf raises on a Smith machine; and dumbbell biceps curls. Resistance for the REx trial will be determined based on the exercise familiarization session. Specifically, we will target a resistance level needed for each participant to complete \~12-15 repetitions per exercise, using proper form, with an RPE of 9-10 on a 10-point scale on final reps. This protocol eliminates the need for max testing in order to set an exercise protocol off of a specific intensity based on % of 1RM.
Sedentary Control Condition First
Sedentary control condition: Participants will sit quietly in a seated position for the entire duration of this condition.
Univeristy of Colorado Anschutz Medical Campus, Aurora
University of Colorado Cancer Center, Denver
Colorado Clinical & Translational Sciences Institute
OTHER
National Center for Advancing Translational Sciences (NCATS)
NIH
National Cancer Institute (NCI)
NIH
University of Colorado, Denver
OTHER